CEDAR KNOLLS, N.J.,
March 10, 2020 /PRNewswire/ -- MYOS
RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a
bionutrition company and the owner of
Fortetropin®, a proprietary
bioactive composition made from fertilized egg yolk that helps
build lean muscle, announced today that it has entered into an
agreement with KVP International, Inc. ("KVP") (www.kvpvet.com),
a leading supplier of innovative
products for the veterinary rehabilitation market such as surgical
supplies, recovery collars and braces.
KVP will distribute, consult, and co-market with MYOS for its
MYOS Canine Muscle Formula®,
Regular and Vet Strength (collectively,
"MYOS Canine"), an advanced nutrition product that has been
clinically shown to increase muscle mass, prevent atrophy of disuse
and improve recovery from injury and surgery.
"KVP is a leading supplier of high-quality products for the
animal rehabilitation market," stated Joseph Mannello, CEO of MYOS RENS
Technology. "Some of their products such as
Saf-T-Shield™ animal recovery collars and
KONG® toys and treats are sought
after by veterinarians and dog owners around the world. We
believe KVP's reach into over 10,000 veterinarian practices and
buying groups will create new customers for MYOS' canine products,"
Mannello added. "We will also work with KVP to build our
direct-to-consumer business working with their team and jointly
marketing our products with theirs. KVP's years of experience
in these markets as well as their incredible customer relationships
will help us to rapidly grow our business."
"At KVP, we're constantly looking for new, innovative, and
unique product offerings for our partners and customers," said
Ken Bowman, CEO and President of
KVP, "and MYOS Canine Muscle
Formula® represents just that– a
clinically proven product that creates and extends quality of life
for its users. MYOS Canine Muscle Formula is a great complimentary
product to the work we're already doing in rehabilitation and
recovery, and we're excited to build on our experience in the
industry to help MYOS revolutionize this space."
In 2019, at the North American Veterinary Conference in
Orlando, FL, MYOS released the
results of the Kansas State University
canine clinical study on dogs that consumed MYOS Canine Muscle
Formula following tibial plateau leveling osteotomy (TPLO) surgery
to repair tears of the cranial cruciate ligament (CCL). After
eight weeks, dogs who underwent the surgery and consumed MYOS
Canine Muscle Formula experienced reduced muscle atrophy and
improved recovery compared with dogs that received a
macronutrient-matched placebo. Since the study results were
released, MYOS has initiated another clinical study at Kansas State University to examine the impact of
MYOS Canine Muscle Formula on quality of life and activity in
geriatric dogs.
In addition to the MYOS' distribution partnership with KVP, its
products for the animal health market are available
direct-to-consumer at www.myospet.com, Amazon.com, and
Chewy.com.
About KVP INTERNATIONAL, INC.
Founded in 1964, KVP
entered the veterinary marketplace with the introduction of its
Saf-T-Shield™ Elizabethan Collar. Widely
praised by veterinarians and their technicians as innovative,
highly effective and a great value, the Saf-T-Shield™ Soft Pet
Cloth Recovery Collar set the standard for each and every KVP
product that would follow. More than 50 years later, KVP offers the
world's largest selection of recovery collars– from mice to
mastiffs.
As well as the world's largest selection of recovery collars,
KVP has quality surgical supplies and highly effective patient care
products. KVP proudly carries the full
KONG® catalog including the
veterinary-exclusive
KONG® Blue™ as
well as products from the well-loved brands
FURminator® and Nature's
Miracle™.
About Myos Canine Muscle
Formula®
Myos Canine Muscle Formula
(Regular and Veterinarian Strength) is an
advanced veterinary health supplement to support muscle health in
dogs, featuring Fortetropin® as the
active ingredient. Fortetropin is made through a patented process
that maintains the vital nutrients of fertilized egg yolks to help
build more lean muscle and decrease muscle loss. For more
information, please visit www.myospet.com.
About MYOS RENS Technology Inc.
MYOS RENS Technology
Inc. (MYOS), "The Muscle Company®", is a
Cedar Knolls, NJ-based advanced
nutrition company that develops and markets products that improve
muscle health and performance. MYOS is the owner of
Fortetropin®, a fertilized egg
yolk-based product manufactured via a proprietary process to retain
and optimize its biological activity. Fortetropin has been
clinically shown to increase muscle size, lean body mass and reduce
muscle atrophy. MYOS believes Fortetropin has the potential to
redefine existing standards of physical health and wellness. For
more information, please visit www.myosrens.com.
Forward-Looking Statements
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products, including
MYOS Canine Muscle
Formula®, Yolked®,
Physician Muscle Health Formula®,
Qurr® and MYOS Enteral
Nutrition Formula™, the success of our
research and development, the results of the clinical evaluation
of Fortetropin® and its
effects, the ability to enter into new partnership opportunities
and the success of our existing partnerships, including its
partnership with KVP discussed above, the ability to generate
revenue and cash flow from sales of our products, the ability to
increase our revenue and gross profit margins, the ability to
achieve a sustainable, profitable business, the effect of economic
conditions, the ability to protect our intellectual property
rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in our filings with the Securities and Exchange
Commission. We undertake no obligation to update or revise any
forward-looking statement for events or circumstances after the
date on which such statement is made except as required by
law.
Investor Relations:
MYOS RENS Technology
Joanne Goodford
Phone: 973-509-0444
Email: jgoodford@myoscorp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-rens-announces-distribution-and-co-marketing-agreement-with-kvp-international-a-leading-distributor-of-veterinary-rehabilitation-products-301020018.html
SOURCE MYOS RENS Technology